ERYTECH PHARMA - SPONSORED ADR (PHXM)

CUSIP: 29604W108

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / SPONSORED ADR
Total 13F shares
2,011,390
Share change
+64,834
Total reported value
$11,608,000
Price per share
$5.89
Number of holders
10
Value change
+$370,892
Number of buys
6
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 29604W108?
CUSIP 29604W108 identifies PHXM - ERYTECH PHARMA - SPONSORED ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ERYTECH PHARMA - SPONSORED ADR (PHXM) as of Q3 2021

As of 30 Sep 2021, ERYTECH PHARMA - SPONSORED ADR (PHXM) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,011,390 shares. The largest 10 holders included BVF INC/IL, NEA Management Company, LLC, Cannell & Co., SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, GROUP ONE TRADING, L.P., ACT Capital, L.L.C., HARBOUR INVESTMENTS, INC., Tower Research Capital LLC (TRC), and MORGAN STANLEY. This page lists 10 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.